HIV Malignancy Specimens for Research at No Charge
The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications to expand the research scope and leverage the …
This initiative will support intervention research that addresses structural racism and discrimination (SRD) in order to improve minority health or reduce health disparities. Earliest submission date: February 24, 2023 Letter …
Through this Funding Opportunity Announcement (FOA) RFA-CA-22-051, the National Cancer Institute (NCI) solicits applications from institutions/organizations to participate as Clinical Sites for the HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network. …
From Cancer Moonshot Scholars program, originally published by the National Cancer Institute “The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers …
The NIH Office of AIDS Research (OAR) is working with All of Us Research Program to advance precision medicine All of Us to award up to $2 million in FY22 …
The purpose of this Notice is to encourage current funded NCI extramural investigators to apply for administrative supplements to support mentored cancer research career development of early-stage low- and middle-income …
The American Association for Cancer Research (AACR)-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship provides a two-year grant of $120,000 to support the salary and benefits of a postdoctoral or clinical research …
The ACSR is pleased to share the following NIH/NCI funding opportunities. 1. Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research in HIV/AIDS Cancer Research Projects at …
NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement …
RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement …
